Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Study

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen

International Journal of Urology ◽

10.1111/j.1442-2042.2010.02473.x ◽

2010 ◽

Vol 17 (4) ◽

pp. 337-345 ◽

Cited By ~ 14

Author(s):

Kazutaka Narimoto ◽

Atsushi Mizokami ◽

Kouji Izumi ◽

Shinya Mihara ◽

Kiyoshi Sawada ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Predictors Of Outcome ◽

Adrenal Androgen ◽

Combined Androgen Blockade ◽

Castration Resistant ◽

Androgen Levels ◽

Androgen Blockade

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

BMC Urology ◽

10.1186/s12894-017-0261-z ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 1

Author(s):

Yoshiyuki Miyazawa ◽

Yoshitaka Sekine ◽

Takahiro Syuto ◽

Masashi Nomura ◽

Hidekazu Koike ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Gonadotropin Releasing Hormone ◽

Adrenal Androgen ◽

Releasing Hormone ◽

PD61-12 CONSIDERATION OF CORRELATION BETWEEN CHANGES IN SERUM ADRENAL ANDROGEN LEVELS AND LOWER URINARY TRACT SYMPTOMS IN PROSTATE CANCER PATIENTS WITH ADMINISTRATION OF GNRH ANTAGONIST

The Journal of Urology ◽

10.1097/01.ju.0000557244.77784.03 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Yoshiyuki Miyazawa* ◽

Akira Ohtsu ◽

Daisuke Oka ◽

Tomomi Saito ◽

Hiroshi Nakayama ◽

...

Keyword(s):

Prostate Cancer ◽

Urinary Tract ◽

Cancer Patients ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Gnrh Antagonist ◽

Adrenal Androgen ◽

Urinary Tract Symptoms ◽

Androgen Levels ◽

Lower Urinary

MP50-09 LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS

The Journal of Urology ◽

10.1016/j.juro.2016.02.443 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Yoshiyuki Miyazawa ◽

Haruo Kato ◽

Yosuke Furuya ◽

Takashi Nitta ◽

Yoshitaka Sekine ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Cancer Patients ◽

Adrenal Androgen ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone ◽

Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated on Cancer and Leukemia Group B (CALGB) 9480

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4557 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4557-4557

Author(s):

M.-E. Taplin ◽

D. J. George ◽

S. Halabi ◽

W. R. Sellers ◽

B. Sanford ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Chromogranin A ◽

Prognostic Significance ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Group B ◽

Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated on Cancer and Leukemia Group B (CALGB) 9480

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4557 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4557-4557

Author(s):

M.-E. Taplin ◽

D. J. George ◽

S. Halabi ◽

W. R. Sellers ◽

B. Sanford ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Chromogranin A ◽

Prognostic Significance ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Group B ◽

Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands

Journal of Andrology ◽

10.2164/jandrol.112.016493 ◽

2012 ◽

Vol 33 (6) ◽

pp. 1233-1238 ◽

Cited By ~ 14

Author(s):

M. Nishii ◽

M. Nomura ◽

Y. Sekine ◽

H. Koike ◽

H. Matsui ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Cancer Patients ◽

Adrenal Glands ◽

Adrenal Androgen ◽

Releasing Hormone ◽

Lh Releasing Hormone ◽

Clinical Outcomes by Age in Men With Hormone Refractory Prostate Cancer: A Pooled Analysis of 8 Cancer and Leukemia Group B (CALGB) Studies

The Journal of Urology ◽

10.1016/s0022-5347(06)00566-0 ◽

2006 ◽

Vol 176 (1) ◽

pp. 81-86 ◽

Cited By ~ 13

Author(s):

Susan Halabi ◽

Nicholas J. Vogelzang ◽

San-San Ou ◽

Wm. Kevin Kelly ◽

Eric J. Small

Keyword(s):

Prostate Cancer ◽

Clinical Outcomes ◽

Pooled Analysis ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Group B ◽

Quality of Life of Early Stage Breast Cancer Patients 65 Years Old or Older Randomized to Standard Chemotherapy or Capecitabine: A Cancer and Leukemia Group B Study (CALGB 49907).

10.1158/0008-5472.sabcs-09-5035 ◽

2009 ◽

Cited By ~ 1

Author(s):

A. Kornblith ◽

L. Archer ◽

L. Lan ◽

G. Kimmick ◽

A. Partridge ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Patients ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Breast Cancer Patients ◽

Standard Chemotherapy ◽

Group B ◽

Use of adrenal androgen levels to predict response to ketoconazole in patients with androgen independent prostate cancer: Results from CALGB 9583

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4558 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4558-4558

Author(s):

C. J. Ryan ◽

S. Halabi ◽

E. Kaplan ◽

N. Vogelzang ◽

P. Kantoff ◽

...

Keyword(s):

Prostate Cancer ◽

Adrenal Androgen ◽

Androgen Levels ◽

Androgen Independent